Our previous study has shown that serum levels of oxLDL (oxidized LDL) are increased and associated with CRP and ROS (reactive oxygen species) levels in COPD patients [24] and oxLDL can induce the production of FABP4 [25,26]. This evidence concerns the gene FABP4 and chronic obstructive pulmonary disease.